Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Other Working Capital Changes (2018 - 2025)

Historic Other Working Capital Changes for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to -$2.0 million.

  • Precision Biosciences' Other Working Capital Changes fell 25851.45% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year increase of 9772.4%. This contributed to the annual value of -$58.9 million for FY2024, which is 3393.41% down from last year.
  • As of Q3 2025, Precision Biosciences' Other Working Capital Changes stood at -$2.0 million, which was down 25851.45% from $2.9 million recorded in Q2 2025.
  • Over the past 5 years, Precision Biosciences' Other Working Capital Changes peaked at $92.9 million during Q1 2021, and registered a low of -$86.8 million during Q2 2021.
  • For the 5-year period, Precision Biosciences' Other Working Capital Changes averaged around -$4.3 million, with its median value being -$6.2 million (2023).
  • Over the last 5 years, Precision Biosciences' Other Working Capital Changes had its largest YoY gain of 305998.73% in 2021, and its largest YoY loss of 840293.83% in 2021.
  • Precision Biosciences' Other Working Capital Changes (Quarter) stood at -$8.0 million in 2021, then fell by 23.03% to -$9.9 million in 2022, then surged by 36.8% to -$6.2 million in 2023, then skyrocketed by 91.97% to -$500000.0 in 2024, then crashed by 295.8% to -$2.0 million in 2025.
  • Its last three reported values are -$2.0 million in Q3 2025, $2.9 million for Q2 2025, and -$1.8 million during Q1 2025.